BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35585577)

  • 21. Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone.
    Tseng CH
    Aging Dis; 2020 May; 11(3):658-667. PubMed ID: 32489710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients.
    Tseng CH
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Tseng CH
    World J Mens Health; 2023 Jan; 41(1):119-128. PubMed ID: 35274506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus.
    Tseng CH
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29954747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
    Chin-Hsiao T
    Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
    Tseng CH
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1389-1400. PubMed ID: 36939574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients.
    Tseng CH
    Aging (Albany NY); 2019 May; 11(9):2724-2734. PubMed ID: 31085804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
    Tseng CH
    Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Tseng CH
    Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.
    Tseng CH
    Front Oncol; 2020; 10():587666. PubMed ID: 33194743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.